These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31835371)

  • 1. The Potential Use of Resveratrol for Cancer Prevention.
    Vervandier-Fasseur D; Latruffe N
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer.
    Han Y; Jo H; Cho JH; Dhanasekaran DN; Song YS
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol in Cancer Patients: From Bench to Bedside.
    Berretta M; Bignucolo A; Di Francia R; Comello F; Facchini G; Ceccarelli M; Iaffaioli RV; Quagliariello V; Maurea N
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and cellular mechanisms of cancer prevention.
    Shukla Y; Singh R
    Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol Action on Lipid Metabolism in Cancer.
    Kisková T; Kassayová M
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways.
    Poortalebi H; ZareDini M; Foroughi-Nematollahi S; Farkhondeh T; Samarghandian S; Pourhanifeh MH
    Curr Med Chem; 2024; 31(27):4340-4361. PubMed ID: 38303533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies.
    Espinoza JL; Kurokawa Y; Takami A
    Blood Rev; 2019 Jan; 33():43-52. PubMed ID: 30005817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models.
    Sudha T; El-Far AH; Mousa DS; Mousa SA
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32244860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.
    Ferraz da Costa DC; Fialho E; Silva JL
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives.
    Cocetta V; Quagliariello V; Fiorica F; Berretta M; Montopoli M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol: Review on its discovery, anti-leukemia effects and pharmacokinetics.
    Huang XT; Li X; Xie ML; Huang Z; Huang YX; Wu GX; Peng ZR; Sun YN; Ming QL; Liu YX; Chen JP; Xu SN
    Chem Biol Interact; 2019 Jun; 306():29-38. PubMed ID: 30954463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics.
    Patra S; Pradhan B; Nayak R; Behera C; Rout L; Jena M; Efferth T; Bhutia SK
    Semin Cancer Biol; 2021 Aug; 73():310-320. PubMed ID: 33152486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention in experimental animals.
    Namasivayam N
    Ann N Y Acad Sci; 2011 Jan; 1215():60-71. PubMed ID: 21261642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling metastatic cancer: the role of phytochemicals in cell signaling.
    Kapinova A; Kubatka P; Liskova A; Baranenko D; Kruzliak P; Matta M; Büsselberg D; Malicherova B; Zulli A; Kwon TK; Jezkova E; Blahutova D; Zubor P; Danko J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1087-1109. PubMed ID: 30903319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol: Targeting Cancer Stem Cells and ncRNAs to Overcome Cancer Drug Resistance.
    Rezakhani L; Salmani S; Eliyasi Dashtaki M; Ghasemi S
    Curr Mol Med; 2024; 24(8):951-961. PubMed ID: 37592772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits the growth of tumor cells under chronic stress via the ADRB‑2‑HIF‑1α axis.
    Ma J; Xue M; Zhang S; Cheng L; Qian W; Duan W; Shen X
    Oncol Rep; 2019 Feb; 41(2):1051-1058. PubMed ID: 30535465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol nanoformulation for cancer prevention and therapy.
    Siddiqui IA; Sanna V; Ahmad N; Sechi M; Mukhtar H
    Ann N Y Acad Sci; 2015 Aug; 1348(1):20-31. PubMed ID: 26109073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
    Cal C; Garban H; Jazirehi A; Yeh C; Mizutani Y; Bonavida B
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):77-93. PubMed ID: 12678904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.
    Kiskova T; Kubatka P; Büsselberg D; Kassayova M
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol effects in oral cancer cells: a comprehensive review.
    Almeida TC; da Silva GN; de Souza DV; de Moraes Malinverni AC; Aguiar O; Estadella D; Ribeiro DA
    Med Oncol; 2021 Jul; 38(8):97. PubMed ID: 34273003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.